4 November 2025
Latham & Watkins Advises Arcus Biosciences in US$250 Million Public Offering of Common Stock
Advising firms
Deal team
15 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Mark Roeder Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| John Williams Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Caitlin Nguyen | Latham & Watkins LLP | Associate | corporate | Not stated |
| Eddie Magana | Latham & Watkins LLP | Associate | corporate | Not stated |
| Connor McCroskey | Latham & Watkins LLP | Not stated | corporate | Not stated |
| Christopher Hazuka | Latham & Watkins LLP | Partner | intellectual property | San Diego |
| Robert Yeh | Latham & Watkins LLP | Counsel | intellectual property | San Diego |
| Kristina Funahashi | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | regulatory | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Counsel | regulatory | Washington, D.C. |
| Evan Miller | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Dennis Poehland | Latham & Watkins LLP | Associate | tax | Not stated |
| Jay Metz | Latham & Watkins LLP | Partner | compensation and benefits | Bay Area |
Stated terms
- Stated value
- USD 250m (US$250 million)
- What the figure measures
- Issue size
- Client
- Arcus BiosciencesIssuer
- Counterparties
- Not stated